Isolated loss of PMS2 expression in colorectal cancers: Frequency, patient age, and familial aggregation

Sharlene Gill, Noralane M. Lindor, Lawrence J. Burgart, Regenia Smalley, Olga Leontovich, Amy French, Richard M. Goldberg, Daniel J. Sargent, Jeremy R. Jass, John L. Hopper, Mark A. Jenkins, Joanne Young, Melissa A. Barker, Michael D. Walsh, Andrew R. Ruszkiewicz, Stephen N. Thibodeau

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

Purpose: Most colorectal cancers that have high levels of microsatellite instability (MSI-H) show loss of immunohistochemical expression of proteins that participate in the DNA mismatch repair process, most often involving MLH1 and MSH2. Less commonly, a third DNA mismatch repair protein, MSH6, may also be lost as the primary event. Rarely, tumors with MSI-H show normal expression of these three proteins. The genetic deficiency leading to the MSI-H phenotype in such cases is unknown. PMS2 is another member of the DNA mismatch repair complex. Its expression is generally lost in tumors with MLH1 loss of expression. Rarely, there is selective loss of PMS2 expression. We sought to describe the frequency and clinical correlates of selective loss of expression of PMS2 with the MSI-H tumor phenotype. Experimental Design: Two thousand seven hundred nineteen colorectal cancers from both clinic- and research-based ascertainment were studied. Tumor MSI testing and immuno-histochemistry for MLH1, MSH2, MSH6, and PMS2 were conducted. Medical records were abstracted for age at diagnosis, gender, colorectal cancer site, and family history. Results: Five hundred thirty-five of the 2,719 tumors were MSI-H. Of these, 93% showed loss of expression of MLH1, MSH2, and/or MSH6. Thirty-eight showed normal expression for these proteins. PMS2 immunohistochemical staining was successful in 32 of 38 of these tumors. Of the 32, 23 showed selective loss of expression of PMS2. This was associated with young age of diagnosis and right-sided location but not with a striking family history of cancer. Conclusions: Overall, 97% of the MSI-H tumors showed loss of expression for one or more of these four mismatch repair proteins. Selective loss of expression of PMS2 was present in 72% of cases in which colorectal cancers had an MSI-H phenotype but no alteration of expression of MLH1, MSH2, and MSH6. The underlying mechanism involved cannot be determined from this study but could involve point mutations in other DNA mismatch repair genes with retention of immunohistochemical expression, somatic inactivation of PMS2, or germ line mutation of PMS2.

Original languageEnglish (US)
Pages (from-to)6466-6471
Number of pages6
JournalClinical Cancer Research
Volume11
Issue number18
DOIs
StatePublished - Sep 15 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Isolated loss of PMS2 expression in colorectal cancers: Frequency, patient age, and familial aggregation'. Together they form a unique fingerprint.

  • Cite this

    Gill, S., Lindor, N. M., Burgart, L. J., Smalley, R., Leontovich, O., French, A., Goldberg, R. M., Sargent, D. J., Jass, J. R., Hopper, J. L., Jenkins, M. A., Young, J., Barker, M. A., Walsh, M. D., Ruszkiewicz, A. R., & Thibodeau, S. N. (2005). Isolated loss of PMS2 expression in colorectal cancers: Frequency, patient age, and familial aggregation. Clinical Cancer Research, 11(18), 6466-6471. https://doi.org/10.1158/1078-0432.CCR-05-0661